(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Complimentary - An Examination of Risk & Outcomes in Outsourcing: To Effectively Mitigate Risk, First Know its Source

Overview

This On Demand Webinar is available through December 1, 2016

 

 

This Solution Provider Webinar is brought to you by DIA in cooperation with Cytel.

Time and again, we hear that “outsourcing key clinical functions is a clinical development risk mitigation strategy.”  But are you really certain of the specific risks and the effective strategies required to succeed in the increasingly complex and high stakes field of today’s clinical research?
 
Little wonder why so many sponsors are ultimately less than satisfied with their outsourcing efforts: Sponsor companies really don't know what they should be considering and how to go about outsourcing to succeed.
 
Steve Herbert of Cytel redefines risk in modern biopharma and device development.  In doing so he reveals how you’re likely under-appreciating the importance – the wider implications – of your biostats and data handling resource assumptions.
TO REGISTER AND VIEW THIS EVENT PLEASE CLICK HERE
 

Featured topics

  • Examining the shifting global economic trends that compel outsourcing of clinical functions
  • Defining risk in the specific context of drug development
  • What are sponsors missing? Exploring the top reasons most outsourcing initiatives disappoint
  • Analyzing how one sponsor-provider partnership succeeded by prioritizing the strategic imperatives beyond cost savings
  • Determining where biometrics matter most in the course of development operationally and strategically: Examples of avoidable breakdowns
  • Going forward: How will biometrics play an even more compelling role as drug development evolves

What you will learn

At the conclusion of this On Demand Webinar, participants should be able to:

  • A coherent way to categorize risk in contemporary biopharma development
  • How clinical outsourcing effects risk, cost & outcome in both good and bad ways
  • Why you need to pay closer attention to your biostats & data management providers
  • How to better use clinical outsourcing – and specifically, biometrics-focused outsourcing – to truly reduce risk

Who should attend?

  • Pharmaceutical Development Executives
  • Strategic Relationship/Sourcing/FSP Managers
  • Clinical Functions/Outsourcing Decision-Makers
  • Biopharm/Biotech CSO, CMO, CFO, COO’s
  • Therapeutic Heads
  • Program and Portfolio Managers
  • Biostatisticians
  • Statistical Programmers
  • Clinical Data Managers

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.